Browsing Category

Top Industry News

7667 posts

Lilly Breaks Ground on $6.5-Bn Houston API Manufacturing Facility 
By

By
Eli Lilly and Company has broken ground on its previously announced $6.5-billion small-molecule medicines and advanced therapeutics manufacturing facility in Houston, Texas. The facility is part of the company’s $50-billion…

European Executives Call on National Govt’s To Prioritize Pharma Industry 
By

By
The Chairs of eight European and globally headquartered bio/pharmaceutical companies (AstraZeneca, Boehringer Ingelheim, Chiesi Group, Ipsen, GSK, Novo, Novartis, Roche, and Sanofi) issued an Open Letter calling on European policymakers…

European Pharma Industry Comments on Proposed Framework for AI Infrastructure 
By

By
The European Federation of Pharmaceutical Industries and Associations (EFPIA), which represents bio/pharmaceutical innovator companies and national pharmaceutical trade associations, issued a statement to “welcome” the European Commission’s proposal for a…

Radiopharma Companies Telix, ITM To Merge in $2.35-Bn Deal 
By

By
Telix, a Melbourne, Australia-based bio/pharmaceutical company specializing in radiopharmaceuticals, and ITM Isotope Technologies Munich, a Munich, Germany-based manufacturer of radioisotopes and radiopharmaceutical company, have agreed to merge in a deal…

Supplier News: Made Scientific, CordenPharma, WuXi XDC & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Made Scientific, CordenPharma, WuXi XDC, Kincellis, MilliporeSigma, Adragos Pharma, Codis and Sanner.   Biologics Manufacturing * Made Scientific Acquires Cell-therapy Mfg Facility from Resilience *…

Global Briefs: Astellas, Bayer, BI & More 
By

By
A roundup of news from the large and mid-sized bio/pharmaceutical companies featuring Astellas, Bayer, Boehringer Ingelheim, Novo, Novartis, and AbbVie. Highlights below.   For the latest news roundup on small and…

Biotech Briefs: Enveda, Basecamp Research, Lisata & More 
By

By
The latest from small and Emerging Pharma companies featuring Enveda, Basecamp Research, Lisata Therapeutics, Marea Therapeutics and Travere Therapeutics.  For news on the large and mid-sized bio/pharmaceutical companies, see Global…

Novo, Orbis Medicines in $1.4-Bn Oral Macrocylic Cardiometabolic Disease Pact; Forms AI Drug-Discovery Pact with Anthropic 
By

By
Novo (formerly called Novo Nordisk) and Orbis Medicines, a Copenhagen, Denmark-based company specializing in oral macrocycle drug discovery, have entered an agreement to discover and develop oral macrocycle therapeutics for…

Roche, Dualitas in $1-Bn Bispecific Antibody Immunology & Inflammation Disease Pact
By

By
Roche and Dualitas Therapeutics, a South San Francisco, California-based bio/pharmaceutical company focused on bispecific antibody therapies for immunology and inflammation (I&I) indications, have entered an agreement to advance bispecific antibodies…

Supplier News: Evonik, Hovione, Lonza & More 
By

By
The latest from CDMOs, CMOs, and suppliers featuring Evonik, Hovione, Lonza, Neuland Laboratories, European RNA Alliance, Argonaut, Bend Bioscience, Symbiosis, Ecolab and Piramal Pharma Solutions.   Chemicals/Chemical API Manufacturing * Neuland Laboratories…